Direct purchasers of Colcrys file US antitrust claims against Takeda, Par, Teva
MLex Summary: Direct purchasers of Colcrys filed a US antitrust complaint against Takeda Pharmaceuticals, Teva Pharmaceutical, and Par Pharmaceutical accusing them of conspiring to limit competition to Takeda’s branded and ‘authorized...To view the full article, register now.
Already a subscriber? Click here to view full article